Ligand validation:6SPQ

MET: METHIONINE

MET is a Ligand Of Interest in 6SPQ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6SPQ_MET_A_702	95%	47%	0.086	0.99	0.96	1.09	1	-	0	0	100%	1
6SPO_MET_A_606	95%	46%	0.087	0.989	1.07	1.02	1	-	0	0	100%	1
3H99_MET_A_602	89%	19%	0.094	0.972	2.39	1.09	1	-	0	0	100%	1
1F4L_MET_A_601	85%	55%	0.1	0.964	1.03	0.7	1	-	0	0	100%	1
3AYL_MET_A_905	99%	42%	0.048	0.984	1.31	0.94	1	-	1	0	100%	1
3IIX_MET_A_1401	99%	51%	0.056	0.989	0.78	1.09	-	1	0	0	100%	1
5URB_MET_A_603	99%	43%	0.06	0.989	0.94	1.27	1	2	0	0	100%	1
5EXK_MET_A_404	98%	37%	0.067	0.99	0.88	1.56	1	2	0	0	100%	1
5FEZ_MET_A_409	97%	62%	0.066	0.979	0.5	0.95	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.